Sector
PharmaceuticalsOpen
₹1,809.1Prev. Close
₹1,794.5Turnover(Lac.)
₹31.51Day's High
₹1,830Day's Low
₹1,80052 Week's High
₹3,37952 Week's Low
₹1,242.95Book Value
₹405.03Face Value
₹10Mkt Cap (₹ Cr.)
1,535.49P/E
48.29EPS
37.43Divi. Yield
0.3910 May 2024
12:00 AM
Dividend
Dividend Amount: 6
26 Jul 2024
12:00 AM
AGM
Announcement Date: 26 Jul, 2024
2 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 8.51 | 8.51 | 8.51 | 8.51 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 304.21 | 283.88 | 259.93 | 229.07 |
Net Worth | 312.72 | 292.39 | 268.44 | 237.58 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 219.35 | 208.47 | 169.42 | 134.78 |
yoy growth (%) | 5.21 | 23.04 | 25.7 | 9.32 |
Raw materials | -61.7 | -53.39 | -22.74 | -23.31 |
As % of sales | 28.12 | 25.61 | 13.42 | 17.29 |
Employee costs | -39.11 | -33.45 | -37.15 | -22.28 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 53.25 | 60.06 | 41.22 | 43.7 |
Depreciation | -9.5 | -9.63 | -9.38 | -5.45 |
Tax paid | -13.73 | -14.88 | -10 | -13.14 |
Working capital | 22.11 | 12.78 | 30.69 | 13.13 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 5.21 | 23.04 | 25.7 | 9.32 |
Op profit growth | -15.86 | 36.55 | 6.29 | 20.73 |
EBIT growth | -12.94 | 38.35 | 0.52 | 26.8 |
Net profit growth | -0.96 | 27.79 | 2.17 | 22.52 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 311.1 | 304.55 | 266.09 | 235.01 | 214.33 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 311.1 | 304.55 | 266.09 | 235.01 | 214.33 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 8.02 | 15.25 | 19.56 | 14.16 | 4.68 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,662.5 | 93.33 | 3,99,045.4 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,844.5 | 82.22 | 1,81,611.04 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,477.8 | 24.79 | 1,19,322.68 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,339.4 | 59.72 | 1,13,003.55 | 474 | 0.18 | 2,385 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,262.6 | 19.53 | 1,05,090.54 | 1,200.7 | 0.63 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
Bhupendra V Gandhi
Non Executive Director
Sanjiv D Gandhi
Alternate Director
Nina Gandhi
Independent Director
Sandhya Patel
Independent Director
Ashok Bhadakal
Independent Director
Ameet Desai
Managing Director & CEO
Rajiv D Gandhi
Non Executive Director
Ravin Gandhi
Executive Director
PRIYA RAJIV GANDHI
Independent Director
Anil Jain
Independent Director
Jatin Yagneshbhai Trivedi
1st Flr PushpakPachvati Circle,
Motilal Hirabhai Road,
Gujarat - 380006
Tel: 91-079-26445107
Website: http://www.hester.in
Email: investor@hesterbiosciences.co.in
5th Floor 506 to 508,
ABC-I Off C G Road, Navrangpura,
Ahmedabad-380009
Tel: 91-79-26465179
Website: https://in.mpms.mufg.com/
Email: ipo.team@linkintime.co.in
Summary
Hester Biosciences Limited is one of the leading and pioneering animal healthcare companies in India. The Company was incorporated in April, 1987 and is principally engaged in manufacturing of Poultry...
Read More
Reports by Hester Biosciences Ltd
What is the Hester Biosciences Ltd share price today?
What is the Market Cap of Hester Biosciences Ltd?
What is the PE and PB ratio of Hester Biosciences Ltd?
What is the 52 Week High and Low of Hester Biosciences Ltd?
What is the CAGR of Hester Biosciences Ltd?
What is the shareholding pattern of Hester Biosciences Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.